Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1.
Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1.
复制标题
DOI:
10.1371/journal.ppat.1006855
复制
发表时间:
2018-01
期刊:
影响因子:
6.7
通讯作者:
Alsford S
中科院分区:
文献类型:
--
作者:
Currier RB;Cooper A;Burrell-Saward H;MacLeod A;Alsford S
In contrast to Trypanosoma brucei gambiense and T. b. rhodesiense (the causative agents of human African trypanosomiasis), T. b. brucei is lysed by apolipoprotein-L1 (apoL1)-containing human serum trypanolytic factors (TLF), rendering it non-infectious to humans. While the mechanisms of TLF1 uptake, apoL1 membrane integration, and T. b. gambiense and T. b. rhodesiense apoL1-resistance have been extensively characterised, our understanding of the range of factors that drive apoL1 action in T. b. brucei is limited. Selecting our bloodstream-form T. b. brucei RNAi library with recombinant apoL1 identified an array of factors that supports the trypanocidal action of apoL1, including six putative ubiquitin modifiers and several proteins putatively involved in membrane trafficking; we also identified the known apoL1 sensitivity determinants, TbKIFC1 and the V-ATPase. Most prominent amongst the novel apoL1 sensitivity determinants was a putative ubiquitin ligase. Intriguingly, while loss of this ubiquitin ligase reduces parasite sensitivity to apoL1, its loss enhances parasite sensitivity to TLF1-dominated normal human serum, indicating that free and TLF1-bound apoL1 have contrasting modes-of-action. Indeed, loss of the known human serum sensitivity determinants, p67 (lysosomal associated membrane protein) and the cathepsin-L regulator, ‘inhibitor of cysteine peptidase’, had no effect on sensitivity to free apoL1. Our findings highlight a complex network of proteins that influences apoL1 action, with implications for our understanding of the anti-trypanosomal action of human serum. Expression of the trypanolytic serum component, apolipoprotein-L1 (apoL1), by humans and the concomitant evolution of countermeasures by two African trypanosome sub-species defines their ability to cause disease in humans. A genome-scale RNAi screen identified more than 60 proteins that sensitise non-human infectious trypanosomes to apoL1. Comparing these outputs to previous screens that used different selection approaches provides insights into the mode-of-action of human serum-mediated killing of trypanosomes. The effectiveness of apoL1, and the trypanolytic factors (TLF) that carry it, is dependent on the parasite’s endocytic system for uptake, intracellular transit and delivery to target membranes. Comparing our current data to the outputs from previous screens revealed that apoL1 is able to exploit different routes to access its target membranes, depending on whether it is free or, as in human serum, complexed with TLF1 or TLF2.
登录
查看更多内容
DOI:
10.1126/science.1193032
发表时间:
2010-08-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Genovese G;Friedman DJ;Ross MD;Lecordier L;Uzureau P;Freedman BI;Bowden DW;Langefeld CD;Oleksyk TK;Uscinski Knob AL;Bernhardy AJ;Hicks PJ;Nelson GW;Vanhollebeke B;Winkler CA;Kopp JB;Pays E;Pollak MR
通讯作者:
Pollak MR
影响因子:
9.6
作者:
Baker N;de Koning HP;Mäser P;Horn D
通讯作者:
Horn D
影响因子:
2.4
作者:
Alsford S;Kelly JM;Baker N;Horn D
通讯作者:
Horn D
DOI:
10.1073/pnas.1505411112
发表时间:
2015-07-21
影响因子:
11.1
作者:
Baker, Nicola;Hamilton, Graham;Horn, David
通讯作者:
Horn, David
影响因子:
5.2
作者:
Bullard, Whitney;Kieft, Rudo;Hajduk, Stephen L.
通讯作者:
Hajduk, Stephen L.